A new study presents a protocol to differentiate human induced pluripotent stem cells (iPSCs) into microglia that closely resemble their in vivo counterparts. These cells offer an exciting new tool for learning more about the role of microglia in disease.
References
Hong, S. & Stevens, B. Dev. Cell 38, 126–128 (2016).
Sterneckert, J.L., Reinhardt, P. & Schöler, H.R. Nat. Rev. Genet. 15, 625–639 (2014).
Muffat, J. et al. Nat. Med. 22, 1358–1367 (2016).
Ginhoux, F. et al. Science 330, 841–845 (2010).
Hickman, S.E. et al. Nat. Neurosci. 16, 1896–1905 (2013).
Gomez Perdiguero, E. et al. Nature 518, 547–551 (2015).
Mass, E. et al. Science, http://dx.doi.org/10.1126/science.aaf4238 (2016).
Lavin, Y. et al. Cell 159, 1312–1326 (2014).
Gosselin, D. et al. Cell 159, 1327–1340 (2014).
Li, Y. et al. Cell Stem Cell 13, 446–458 (2013).
Schafer, D.P. et al. eLife 5, e15224 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Hammond, T., Stevens, B. Increasing the neurological-disease toolbox using iPSC-derived microglia. Nat Med 22, 1206–1207 (2016). https://doi.org/10.1038/nm.4226
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4226
- Springer Nature America, Inc.
This article is cited by
-
The fusiform gyrus exhibits an epigenetic signature for Alzheimer’s disease
Clinical Epigenetics (2020)
-
Modeling neurological disease using human stem cell-derived microglia-like cells transplanted into rodent brains
Lab Animal (2020)
-
An updated assessment of microglia depletion: current concepts and future directions
Molecular Brain (2017)
-
Microglia emerge as central players in brain disease
Nature Medicine (2017)